# A Research Study to See How a New Medicine (NNC0487-0111) Works in People With Overweight or Obesity When Injected Under the Skin

> **NCT06064006** · PHASE2 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 125 (actual)

## Conditions studied

- Obesity
- Overweight

## Interventions

- **DRUG:** NNC0487-0111
- **DRUG:** Placebo (NNC0487-0111)

## Key facts

- **NCT ID:** NCT06064006
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-15
- **Primary completion:** 2024-11-27
- **Final completion:** 2024-11-27
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2025-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06064006

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06064006, "A Research Study to See How a New Medicine (NNC0487-0111) Works in People With Overweight or Obesity When Injected Under the Skin". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06064006. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*